These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11932962)

  • 1. Influence of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers.
    Kang BC; Yang CQ; Cho HK; Suh OK; Shin WG
    Biopharm Drug Dispos; 2002 Mar; 23(2):77-81. PubMed ID: 11932962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms.
    Chen BL; Chen Y; Tu JH; Li YL; Zhang W; Li Q; Fan L; Tan ZR; Hu DL; Wang D; Wang LS; Ouyang DS; Zhou HH
    J Clin Pharmacol; 2009 May; 49(5):574-81. PubMed ID: 19398604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin.
    Böttiger Y; Tybring G; Götharson E; Bertilsson L
    Clin Pharmacol Ther; 1997 Oct; 62(4):384-91. PubMed ID: 9357389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole.
    Fan L; Wang G; Wang LS; Chen Y; Zhang W; Huang YF; Huang RX; Hu DL; Wang D; Zhou HH
    Acta Pharmacol Sin; 2007 Oct; 28(10):1685-92. PubMed ID: 17883958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes.
    Yang LJ; Fan L; Liu ZQ; Mao YM; Guo D; Liu LH; Tan ZR; Peng L; Han CT; Hu DL; Wang D; Zhou HH
    Eur J Clin Pharmacol; 2009 Jun; 65(6):601-8. PubMed ID: 19172254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
    Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
    J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.
    Uno T; Niioka T; Hayakari M; Yasui-Furukori N; Sugawara K; Tateishi T
    Eur J Clin Pharmacol; 2007 Feb; 63(2):143-9. PubMed ID: 17203292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes.
    Tu JH; Hu DL; Dai LL; Sun Y; Fan L; Zhang M; Tan ZR; Chen Y; Li Z; Zhou HH
    Xenobiotica; 2010 Jun; 40(6):393-9. PubMed ID: 20350051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral omeprazole in llamas.
    Poulsen KP; Smith GW; Davis JL; Papich MG
    J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable omeprazole kinetics in healthy Jordanian adults.
    Albsoul-Younes A; Tayyem R; Najib N
    Biopharm Drug Dispos; 2005 Jul; 26(5):183-8. PubMed ID: 15906422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans.
    Furuta T; Ohashi K; Kobayashi K; Iida I; Yoshida H; Shirai N; Takashima M; Kosuge K; Hanai H; Chiba K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 1999 Sep; 66(3):265-74. PubMed ID: 10511062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of Omeprazole and its metabolites in poor and extensive metabolizer Pakistani healthy volunteers and a review of different studies.
    Ahmad L; Iqbal Z; Shah Y; Nazir S; Khan A; Khan MI; Khan A; Khuda F; Khan I
    Pak J Pharm Sci; 2018 Jul; 31(4):1363-1374. PubMed ID: 30033421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of fluconazole on the pharmacokinetics of rosuvastatin.
    Cooper KJ; Martin PD; Dane AL; Warwick MJ; Schneck DW; Cantarini MV
    Eur J Clin Pharmacol; 2002 Nov; 58(8):527-31. PubMed ID: 12451430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the relationship between polymorphisms in CYP2C19 and the single-dose pharmacokinetics of omeprazole in healthy Chinese volunteers: A multicenter study.
    Zhou S; Xie R; Zhang X; He X; Huang J; Jungang Y; Liao M; Ding Y; Yang D; Liu Y; Zhang Q; Yang G; Liu F; Guan S; He Q; Lou H; Gong F; Meng X; Xiang Q; Zhao X; Cui Y
    Clin Transl Sci; 2022 Jun; 15(6):1439-1448. PubMed ID: 35235711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
    Joti JJ; Nahar K; Hasan A; Azad MA; Ullah MA; Islam SM; Hasnat A
    Arzneimittelforschung; 2009; 59(4):171-5. PubMed ID: 19517893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole absorption from a compounded transdermal formulation in healthy volunteers.
    Haas CE; Lin L; Cloen D; Kufel T; Moon R; Frerichs V
    J Am Pharm Assoc (2003); 2005; 45(4):473-8. PubMed ID: 16128503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of gastric pH on the pharmacokinetics of fluconazole: the effect of omeprazole.
    Zimmermann T; Yeates RA; Riedel KD; Lach P; Laufen H
    Int J Clin Pharmacol Ther; 1994 Sep; 32(9):491-6. PubMed ID: 7820333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in omeprazole pharmacokinetics in a random Iranian population: a pilot study.
    Noubarani M; Kobarfard F; Motevalian M; Keyhanfar F
    Biopharm Drug Dispos; 2012 Sep; 33(6):324-31. PubMed ID: 22890488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspension.
    Song JC; Quercia RA; Fan C; Tsikouris J; White CM
    Am J Health Syst Pharm; 2001 Apr; 58(8):689-94. PubMed ID: 11329761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.